Indian drug makers are launching affordable generic Semaglutide, the active ingredient in popular weight-loss drugs. Sun Pharma, Lupin, and Torrent Pharma are identified as potential market leaders. Despite initial stockouts online, companies are adjusting supply. The market for these diabetes and obesity drugs is expected to grow significantly in India.
Kwality Walls shares fall 3% as RIL’s foray into ice cream biz raises competition fears
Kwality Walls shares dropped on Wednesday as Reliance Consumer Products entered India’s ice cream market with Bombay Creamery, raising competition concerns. The stock extended its